StocksDeepDive
Snapshot · Foreign US-listed · generated 2026-11-11 20:45 UTC

NVO — Novo Nordisk A/S

EXPENSIVE (MOS -11.5%) · Quality 89/100

Price
41.06
Intrinsic value
36.84
Margin of safety
-11.5%
Implied growth (reverse DCF)
+6.8%
model assumes +4.9%
Value Score
38.3
Quality
89
Psychology
11.9
Discovery
9.6
price/volume attention only
Moat score
85
erosion: none

Value Score: top 40% of Foreign US-listed · Quality: top 6%

Dividend: 1.854/share (TTM) · yield 4.5% · payout 47%

Open the interactive Deep Dive for NVO →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/NVO - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is NVO undervalued?

As of 2026-11-11, NVO trades at 41.06 against a computed intrinsic value of 36.84 (-11.5% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Novo Nordisk A/S's Value Score?

Novo Nordisk A/S's Value Score is 38.3 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.

Does NVO pay a dividend?

Yes - NVO's trailing twelve-month dividend is 1.854/share, a yield of 4.5% at the current price (as of 2026-11-11).